Circassia Pharmaceuticals (CSSPF) Ownership - Who Owns Circassia Pharmaceuticals?
Circassia Pharmaceuticals (CSSPF) Ownership Overview
- 2.22% Insiders
- <0.01% Other Institutional Investors
- 0.49% ETFs
- 97.28% Public Companies and Individual Investors
The ownership structure of Circassia Pharmaceuticals (CSSPF) stock is a mix of institutional, retail, and individual investors. Approximately 0.49% of the company’s stock is owned by Institutional Investors, 2.22% is owned by Insiders, and 97.28% is owned by Public Companies and Individual Investors.
The ownership structure of Circassia Pharmaceuticals (CSSPF) stock is a mix of institutional, retail, and individual investors. Approximately 0.49% of the company’s stock is owned by Institutional Investors, 2.22% is owned by Insiders, and 97.28% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Apr 16, 2026 | Jonathan Charles Emms | £183,454 | |
| Apr 16, 2026 | Sarah Duncan | £92,841 | |
| Dec 03, 2025 | Sarah Duncan | £3,901 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ian Roy Johnson | 5,208,288 | Insider | 1.29% | 4,713,501 |
| Jonathan Charles Emms | 3,658,911 | Insider | 0.90% | 3,311,314 |
| Jpmorgan | 1,379,632 | Institution | 0.34% | 1,248,567 |
| Wisdomtree | 609,070 | Institution | 0.15% | 551,208 |
| Sarah Duncan | 137,014 | Insider | 0.03% | 123,998 |
| Ishares | 359 | Institution | <0.01% | 325 |
| Franklin Alternative Strategies Funds | 2 | Institution | 0.00% | 2 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Franklin Alternative Strategies Funds | 2 | Institution | 0.00% | 2 |
FAQ
Who Owns Circassia Pharmaceuticals (CSSPF)?
According to the latest TipRanks data, approximately 0.49% of the company's stock is held by institutional investors, 2.22% is held by insiders, and 97.28% is held by public companies and individual investors.
What percentage of Circassia Pharmaceuticals (CSSPF) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.49% of Circassia Pharmaceuticals (CSSPF) stock is held by institutional investors: 0.49% by ETFs and <0.01% by other institutional investors.
What percentage of Circassia Pharmaceuticals (CSSPF) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.28% of Circassia Pharmaceuticals (CSSPF) stock is held by public companies and individual investors.
Who owns the most shares of Circassia Pharmaceuticals (CSSPF)?
Ian Roy Johnson owns the most shares of Circassia Pharmaceuticals (CSSPF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
